Angela Thedinga
Directeur/Membre du Conseil chez NKARTA, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Angela Thedinga
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NKARTA, INC. | Directeur/Membre du Conseil | 28/03/2022 | - |
| Independent Dir/Board Member | 28/03/2022 | - |
Historique de carrière de Angela Thedinga
Anciens postes connus de Angela Thedinga
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | 25/02/2020 | 01/10/2021 |
| Corporate Officer/Principal | 01/08/2019 | 25/02/2020 | |
| AVEXIS INC | Responsable des Ressources Humaines | 01/07/2018 | 01/06/2019 |
Formation de Angela Thedinga
| Massachusetts Institute of Technology | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
| The University of North Carolina at Chapel Hill | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Graduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Bourse
- Insiders
- Angela Thedinga
- Expérience
